Featured Posts

Uncovering molecular targets for childhood cancer therapeutics

In the past two decades, despite extensive efforts to identify the genes associated with 11q aberrations in NB, definitive answers are still unclear. This distinct gap in the field has spurred a team of Tokyo Medical and Dental University (TMDU)-centered researchers to investigate the role of the gene ATM and DNA damage response (DDR)-associated molecules located in 11q. A report of the results was recently published.

Read more: https://medicalxpress.com/news/2017-12-uncovering-molecular-childhood-cancer-therapeutics.html

Posts Are Coming Soon
Stay tuned...
Recent Posts
Archive
Search By Tags
Follow Us
  • Facebook Basic Square
  • Twitter Basic Square

Email us:

info@opacc.org

A program of OPACC

Call us:

Toll-free: 1-888-290-5496

Local:         705-828-7965

Mail us: 

524 Bayfield Street North
P.O. Box 20005
Barrie, ON L4M 5E9
Canada

 

Subscribe for Updates (if you are the parent of a child with cancer, please fill out the Membership form instead)